A cadre of new scientists is needed to offer novel perspectives and innovative approaches to HIV and substance use research. Previous research has documented the limited numbers of underrepresented ethnically diverse and other underrepresented researchers addressing the HIV pandemic through research careers.[1,2] Pilot studies represent an important opportunity to not only increase the involvement of underrepresented groups of scientific investigators pursuing new research initiatives, but to provide mentoring opportunities critical to the success of emerging scholars. Specifically, pilot projects create opportunities for the further training and career development of new investigators by promoting collaboration with established senior colleagues of the Center. The opportunity for new HIV investigators to gain guidance and support is critical for continued scientific progress towards addressing the HIV epidemic and the role of substance use. The proposed Pilot Projects and Mentoring (PPM) Core will foster opportunities for mentorship and support for new or early stage investigators (those within 10 years of doctoral studies completion) by drawing on a conceptually-driven framework based on the empirical literature on mentoring. The proposed Core, provides short-term support for investigators targeting new research initiatives or testing the feasibility of new research strategies with the goal of obtaining subsequent extramural funding. The overall goal of the PPM is to promote pilot testing of innovative areas of research in the field of HIV and substance use that require preliminary data for subsequent extramural funding.
The specific aims are:
Aim 1. To solicit and review pilot project proposals;
Aim 2. To ensure mentoring and further training of investigators receiving pilot funds and other new or early stage investigators. The PPM Core seeks to support research conducted by the following 4 groups of investigators: 1. New or early stage investigators; 2. Established investigators without prior experience in the field of substance use and HIV research; 3. Established HIV investigators pursuing a new area of inquiry within the field of substance use and HIV research; and ' 4. Established substance use investigators pursuing new research related to HIV. For all of the above categories we will prioritize and support specific groups determined by NIH and NIDA to be nationally underrepresented in the field of HIV and substance use research (PA-08-190, http://grants.nih.gov/grants/guide/pa-files/pa-08-190.html). RFAs will be developed and advertised at the 4 CDUHR-affiliated institutions (NYU, NDRI, BIMC and JJCCJ). Underrepresented groups of new and early stage investigators will be prioritized in the RFA evaluation criteria. A multi-component mentoring structure, based on previous research, will be implemented to support the development of new and early stage investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
4P30DA011041-19
Application #
8974399
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
19
Fiscal Year
2016
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
041968306
City
New York
State
NY
Country
United States
Zip Code
10012
Vasylyeva, Tetyana I; Liulchuk, Mariia; Friedman, Samuel R et al. (2018) Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Proc Natl Acad Sci U S A 115:1051-1056
Wolfson-Stofko, Brett; Elliott, Luther; Bennett, Alex S et al. (2018) Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration. Int J Drug Policy 62:67-73
Palamar, Joseph J (2018) What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA. J Psychoactive Drugs 50:88-93
Wolfson-Stofko, Brett; Gwadz, Marya V; Elliott, Luther et al. (2018) ""Feeling confident and equipped"": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City. Drug Alcohol Depend 192:362-370
Palamar, Joseph J; Acosta, Patricia; Cleland, Charles M (2018) Attitudes and Beliefs About New Psychoactive Substance Use Among Electronic Dance Music Party Attendees. Subst Use Misuse 53:381-390
Williams, Leslie D; Kostaki, Evangelia-Georgia; Pavlitina, Eirini et al. (2018) Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, Greece. Front Microbiol 9:1825
Scheidell, Joy D; Quinn, Kelly; McGorray, Susan P et al. (2018) Childhood traumatic experiences and the association with marijuana and cocaine use in adolescence through adulthood. Addiction 113:44-56
Khan, Maria R; Scheidell, Joy D; Rosen, David L et al. (2018) Early age at childhood parental incarceration and STI/HIV-related drug use and sex risk across the young adult lifecourse in the US: Heightened vulnerability of black and Hispanic youth. Drug Alcohol Depend 183:231-239
Des Jarlais, D C; Cooper, H L F; Arasteh, K et al. (2018) Potential geographic ""hotspots"" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US. PLoS One 13:e0194799
Skaathun, Britt; Khanna, Aditya S; Morgan, Ethan et al. (2018) Network Viral Load: A Critical Metric for HIV Elimination. J Acquir Immune Defic Syndr 77:167-174

Showing the most recent 10 out of 339 publications